Deregulation of Ubiquitin Ligase Fbw7 and its role in Tumor Progression
-
摘要: 泛素蛋白酶系统对于维持细胞正常生理功能具有重要作用,Fbw7 是 E3 泛素连接酶的底物结合单位,参与泛素化降解与细胞增殖、分化、凋亡有关的重要分子,其调控异常在肿瘤细胞中极为常见。Fbw7 调控的底物包括一系列促癌分子和癌症相关转录因子,被认为是重要的抑癌分子。比如 Fbw7 可以通过调控 Cyclin E、c-Myc、Aurora A 减少因细胞周期异常而造成的染色体不稳,通过调控 p63、Mcl1 来影响细胞损伤修复并增加细胞凋亡,通过调控 TGFβ、mTOR 抑制肿瘤转移,再者可以通过对 Notch 和 Bcl2 家族分子的调控增加肿瘤细胞对化疗的敏感性。因此稳定 Fbw7 的表达可以抑制肿瘤表型的产生和发展,本文就 Fbw7 结构功能、突变机制,调控通路及其在肿瘤发生发展中的作用进行综述。Abstract: Ubiquitin proteasome system is physically ess ential to normal cell functions. Fbw7 is a subunit of E3 ligase specifically binding to a series of substrates to promote their lysosomal degradation, the regulation of which is commonly mutated in tumors. Most substrates of Fbw7 are dominant oncogenes, including Cyclin E, c-Myc, Notch, Aurora A, and Mcl1, which intensively regulate cell cycle, DNA repair, metastasis as well as chemoresistance. Therefore, Fbw7 targeting intervention can inhibit malignant transformation of cells. This review focuses on the biological functions, genetic alterations and regulation networks of Fbw7 in order to highlight its role in tumor progression.
-
Key words:
- Fbw7 /
- ubiquitin proteasome system /
- ubiquitin ligase /
- tumor
-
[1] Hershko A, Ciechanover A. The ubiquitin system[J]. Annu Rev Biochem, 1998, 67(4): 425-9. http://cn.bing.com/academic/profile?id=787161cfbd8c5c43960b5dcdbbf98659&encoded=0&v=paper_preview&mkt=zh-cn [2] Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer[J]. Nat Rev Cancer, 2006, 6(5): 369-81. doi: 10.1038/nrc1881 [3] Lau W, Fukushima H, Wei W. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis[J]. Front Biosci,2012, 17(6): 2197-212. http://cn.bing.com/academic/profile?id=3ee47c38e0144e794bb89fa44ee0003a&encoded=0&v=paper_preview&mkt=zh-cn [4] Bredel M, Bredel C, Juric D, et al. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas[J]. Cancer Res, 2005, 65(19): 8679-89. doi: 10.1158/0008-5472.CAN-05-1204 [5] Welcker M, Clurman E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation[J]. Nat Rev Cancer, 2008, 8(2): 83-93. doi: 10.1038/nrc2290 [6] Wang L, Ye XT, Liu YY, et al. Aberrant regulation of FBW7 in cancer[J]. Oncotarget, 2014, 5(8): 2000-15. doi: 10.18632/oncotarget [7] Hao B, Oehlmann S, Sowa E, et al. Structure of a Fbw7-Skp1-cclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases[J]. Mol Cell, 2007, 26(1): 131-43. doi: 10.1016/j.molcel.2007.02.022 [8] Welcker M, Larimore A, Swanger J, et al. Fbw7 dimerization determines the specificity and robustness of substrate degradation[J]. Genes Dev, 2013, 27(23): 2531-6. doi: 10.1101/gad.229195.113 [9] Koepp M, Schaefer K, Ye X, et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase[J]. Science, 2001, 294(40): 173-7. http://cn.bing.com/academic/profile?id=bb4f99e61685127a44599d7dba5e7855&encoded=0&v=paper_preview&mkt=zh-cn [10] Cheng YB, Li G. Role of the ubiquitin ligase Fbw7 in Cancer progression[J]. Cancer Metastasis Rev, 2012, 31(1/2): 75-87. http://cn.bing.com/academic/profile?id=3910e0d1aa52b8c75d52c5ff7ac717e7&encoded=0&v=paper_preview&mkt=zh-cn [11] Akhoondi S, Lindström L, Widschwendter M, et al. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer[J]. Breast Cancer Res, 2010, 12(6): R105-8. doi: 10.1186/bcr2788 [12] Inuzuka H, Shaik S, Onoyama I, et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction[J]. Nature, 2011, 471(36): 104-9. http://d.scholar.cnki.net/detail/SJPD0711_U/SJPD12102000196395 [13] Flügel D, Görlach A, Kietzmann T. GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α[J]. Blood, 2012, 119(5): 1292-301. doi: 10.1182/blood-2011-08-375014 [14] Pérez BB, Farràs R. Regulation of GSK3β-FBXW7-JUNB axis[J]. Oncotarget, 2013, 4(7): 956-7. doi: 10.18632/oncotarget [15] Ren H, Zhao LQ, Li YK, et al. The PI3 kinase inhibitor NVP-BKM120 induces GSK3/FBXW7-dependent Mcl-1 degradation, contributing to induction of apoptosis and enhancement of TRAIL-induced apoptosis[J]. Cancer Lett, 2013,338(2): 229-38. doi: 10.1016/j.canlet.2013.03.032 [16] Mao H, Perez LJ, Wu D, et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene[J]. Nature, 2004, 432(718): 775-9. http://cn.bing.com/academic/profile?id=0d2dda8a8647d3497182d54c2b018086&encoded=0&v=paper_preview&mkt=zh-cn [17] Kurashige J, Watanabe M, Iwatsuki M, et al. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma[J]. Br J Cancer, 2012, 106(1): 182-8. http://cn.bing.com/academic/profile?id=72c94f5dd39659e02a9913464f4ad871&encoded=0&v=paper_preview&mkt=zh-cn [18] Li L, Sarver AL, Khatri R, et al. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma[J]. J Pathol, 2014, 234(4): 488-501. doi: 10.1002/path.2014.234.issue-4 [19] Kumar V, Palermo R, Talora C, et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia[J]. Leukemia, 2014, 28(12): 2324-35. doi: 10.1038/leu.2014.133 [20] Esquejo M, Jeon TI, Osborne F. Lipid-cell cycle nexus: SREBP regulates microRNAs targeting Fbxw7[J]. Cell Cycle, 2014, 13(3):339-40. doi: 10.4161/cc.27509 [21] Balamurugan K, Wang M, Tsai H, et al. The tumour suppressor C/ EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis[J]. EMBO J, 2010, 29(24): 4106-17. doi: 10.1038/emboj.2010.280 [22] Min H, Lau W, Lee H, et al. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase[J]. Mol Cell, 2012, 46(6): 771-83. doi: 10.1016/j.molcel.2012.04.012 [23] Sancho R, Blake M, Tendeng C, et al. Fbw7 repression by hes5 creates a feedback loop that modulates Notch-mediated intestinal and neural stem cell fate decisions[J]. PLoS Biol, 2013, 11(6): e1001586-94. doi: 10.1371/journal.pbio.1001586 [24] Ji S, Qin Y, Shi S, et al. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer[J]. Cell Res, 2015, 25(5): 561-73. doi: 10.1038/cr.2015.30 [25] Evans T, Rosenthal T, Youngblom J, et al. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division[J]. Cell, 1983, 33(2): 389-96. doi: 10.1016/0092-8674(83)90420-8 [26] Hartwell LH, Culotti J. Genetic control of the cell division cycle in yeast [J]. Science, 1974, 183(4120): 46-51. doi: 10.1126/science.183.4120.46 [27] Spruck H, Won A, Reed I. Deregulated cyclin E induces chromosome instability[J]. Nature, 1999, 401(50): 297-300. http://cn.bing.com/academic/profile?id=23d0935935ef8eaf9495e82057660588&encoded=0&v=paper_preview&mkt=zh-cn [28] Minella C, Grim E, Welcker M, et al. p53 and SCFFbw7 cooperatively restrain cyclin e-associated genome instability[J]. Oncogene, 2007, 26(48): 6948-53. doi: 10.1038/sj.onc.1210518 [29] Eilers M, Schirm S, Bishop M. The MYC protein activates transcription of the alpha-prothymosin gene[J]. EMBO J, 1991, 10(1): 133-41. http://cn.bing.com/academic/profile?id=a105ffc277c9e9ab4e715d94002356f4&encoded=0&v=paper_preview&mkt=zh-cn [30] Yada M, Hatakeyama S, Kamura T, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7[J]. EMBO J, 2004, 23(10): 2116-25. doi: 10.1038/sj.emboj.7600217 [31] Artavanis TA, Rand S, Lake RJ,et al.Notch signaling:cell fate control and signal integration in development[J]. Science,1999,32(284): 770–6. http://cn.bing.com/academic/profile?id=4d191757632a88ed362d946606481986&encoded=0&v=paper_preview&mkt=zh-cn [32] Oberg C, Li J, Pauley A, et al. The notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog[J]. J Biol Chem, 2001, 276(38): 35847-53. doi: 10.1074/jbc.M103992200 [33] Fryer J, White B, Jones A. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover[J]. Mol Cell, 2004, 16(4): 509-20. doi: 10.1016/j.molcel.2004.10.014 [34] Ishikawa Y, Onoyama I, Nakayama I, et al. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7[J]. Oncogene, 2008, 27(47): 6164-74. doi: 10.1038/onc.2008.216 [35] Hartl M, Bader G, Bister K. Molecular targets of the oncogenic transcription factor jun[J]. Curr Cancer Drug Targ, 2003, 3(1):41-55. doi: 10.2174/1568009033333781 [36] Musti M, Treier M, Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases[J]. Science, 1997, 275(98): 400-2. http://cn.bing.com/academic/profile?id=f271131d69d52233cfa153737a6acfcb&encoded=0&v=paper_preview&mkt=zh-cn [37] Wei WY, Jin JP, Schlisio S, et al. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase[J]. Cancer Cell, 2005, 8(1): 25-33. doi: 10.1016/j.ccr.2005.06.005 [38] Marumoto T, Zhang D, Saya H. Aurora-A - a Guardian of poles[J]. Nat Rev Cancer, 2005, 5(1): 42-50. doi: 10.1038/nrc1526 [39] Giet R, Petretti C, kinases C.Aurora prigent,aneuploidy and cancer: a coincidence or a real Link[J]. Trends Cell Biol, 2005, 15(7):241-50. http://cn.bing.com/academic/profile?id=2af6e10fb84ccbe97fa036919f91e3c4&encoded=0&v=paper_preview&mkt=zh-cn [40] Kwon W, Kim J, Wu D, et al. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development [J]. Mol Cancer Res, 2012, 10(6): 834-44. doi: 10.1158/1541-7786.MCR-12-0025 [41] Galli F, Rossi M, D'alessandra Y, et al. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation[J]. J Cell Sci, 2010, 123(Pt 14): 2423-33. http://cn.bing.com/academic/profile?id=0d875655fca6ed61422a4889119da98b&encoded=0&v=paper_preview&mkt=zh-cn [42] Massagué J, Wotton D. Transcriptional control by the TGF-beta/ Smad signaling system[J]. EMBO J, 2000, 19(8): 1745-54. doi: 10.1093/emboj/19.8.1745 [43] Bengoechea AT, Ericsson J. Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation[J]. Oncogene,2010, 29(38): 5322-8. doi: 10.1038/onc.2010.278 [44] Wertz IE, Kusam S, Lam C, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7[J]. Nature,2011, 471(7336): 110-4. doi: 10.1038/nature09779 [45] Wolfer A, Ramaswamy S. MYC and metastasis[J]. Cancer Res,2011, 71(63): 2034–7. http://cn.bing.com/academic/profile?id=d9b626eb133cfbf6ea0ff67ab4757476&encoded=0&v=paper_preview&mkt=zh-cn [46] Fletcher JI, Haber M, Henderson MJ. ABC transporters in cancer: more than just drug efflux pumps[J]. Nat Rev Cancer, 2010, 10(2):147-56. doi: 10.1038/nrc2789 [47] Happold C, Roth P, Wick W, et al. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells[J]. J Neurochem, 2012, 122(2): 444-55. doi: 10.1111/jnc.2012.122.issue-2 [48] Zhang JH, Stevens F, Laughton A, et al. Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications[J]. Oncology, 2010, 78(2):103-14. doi: 10.1159/000306139 [49] Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance[J]. Nat Rev Cancer, 2005, 5(4): 275-84. doi: 10.1038/nrc1590 [50] O'neil J, Grim J, Strack P, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors[J]. J Exp Med, 2007, 204(8): 1813-24. doi: 10.1084/jem.20070876
点击查看大图
计量
- 文章访问数: 553
- HTML全文浏览量: 229
- PDF下载量: 3
- 被引次数: 0